NETHERTON SYNDROME
Clinical trials for NETHERTON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NETHERTON SYNDROME trials appear
Sign up with your email to follow new studies for NETHERTON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-of-its-Kind skin treatment trial offers hope for rare genetic disorder
Disease control Recruiting nowThis is the first time a new topical ointment called ATR12-351 is being tested in people. The study aims to see if it is safe and well-tolerated in about 12 adults with Netherton Syndrome, a rare and severe genetic skin condition. The ointment is designed to address the root caus…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1 • Sponsor: Azitra Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
First test of new drug for rare, severe skin disorder begins
Disease control Recruiting nowThis is the first study in people of an experimental drug called BCX17725 for Netherton Syndrome, a rare and serious genetic skin condition. The main goal is to check the drug's safety, how the body processes it, and the right dose. It will first test single and multiple doses in…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC